Methyl 4-(piperidin-4-ylmethyl)benzoate hydrochloride, 95.0%, 250mg

N,N-Dibutylacetamide, 95%, 25g

1-Amino-2-naphthol Hydrochloride>97.0%(HPLC)(N)5g

(E)-4-(benzylamino)-4-oxobut-2-enoic acid, 97%, 250mg

Z-Val-OEt, 95%, 1g

(4-Formyl-3,5-dimethylphenyl)boronic acid, 97%, 1g

2-Bromo-4-methoxy-6-methylpyrimidine, 97%, 250mg

2-Hydroxy-6-trifluoromethyl-pyridine, 97.00%, 100g

1-Thioglycerol>95.0%(GC)100g

((2S,5R)-5-(6-Amino-9H-purin-9-yl)tetrahydrofuran-2-yl)methanol, 95.0%, 250mg

(S)-N-((S)-(3,5-Difluorophenyl)(5-(diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl)methyl)-2-methylpropane-2-sulfinamide, 98%, 100mg

tert-Butyl 4-(5'-bromopyrid-2'-yl)piperazine-1-carboxylate, 95.0%, 25g

1,4-Phenylenediamine, min. 99%, for synthesis, 250 g, glass packaging